FTC requests AbbVie

AbbVie Inc. and Allergan plc, In the Matter of

and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would ...

AbbVie Inc., et al. - Federal Trade Commission

The FTC filed a complaint in federal district court in September 2014 charging that AbbVie Inc. and its partner Besins Healthcare Inc. illegally blocking ...

AbbVie and Allergan Receive Second Request from Federal Trade ...

AbbVie and Allergan (NYSE: AGN) have each received a Request for Additional Information (Second Request) from the Federal Trade Commission (FTC) in connection ...

Federal Trade Commission Withdraws Remaining Case against ...

After the Supreme Court declined to review a ruling from the Third Circuit that AbbVie used sham litigation to illegally maintain a monopoly ...

Allergan and AbbVie Receive Second Request from Federal Trade ...

In connection with the proposed acquisition, Allergan has filed with the U.S. Securities and Exchange Commission (the " SEC ") a definitive ...

Abbvie, Inc. | Federal Trade Commission

Abbvie, Inc. Date Sent. Tuesday, November 7, 2023. File. Abbvie, Inc. (268.33 KB). Related Releases. FTC Challenges More Than 100 Patents as Improperly ...

AbbVie and Allergan Receive Clearance from U.S. Federal Trade ...

The acceptance by the FTC satisfies all required antitrust clearances needed to be obtained for the acquisition of Allergan by AbbVie. As part ...

AbbVie's Cerevel deal hits an uncommon roadblock - BioPharma Dive

Cerevel and AbbVie “expect to promptly respond” to the request and “continue to work cooperatively with the FTC in its review, ...

FTC Approves Final Order Imposing Conditions on AbbVie Inc.'s ...

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that AbbVie's $63 billion ...

FTC Imposes Conditions on AbbVie Inc.'s Acquisition of Allergan plc

Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assets to settle Federal Trade Commission charges that AbbVie's ...

AbbVie's Soliton Acquisition Hits a Snag as FTC Increases Scrutiny

AbbVie's Allergan Aesthetics announced it was buying Soliton in a deal worth about $550 million. Now, the Federal Trade Commission has requested additional ...

AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy

CEO Richard Gonzalez was clear that AbbVie did its due diligence and he does not expect big problems from the US Federal Trade Commission.

FTC requests AbbVie, Allergan for more information on $63 billion ...

The U.S. Federal Trade Commission (FTC) has requested for more information from AbbVie Inc and botox maker Allergan Plc

FTC's watchdog role in pharma mergers: Road bumps and the way ...

... FTC pertained to the agency's finalized second request about AbbVie's proposed acquisition of Cerevel Therapeutics. The acquisition, disclosed in December ...

AbbVie, Allergan score FTC approval for $63B merger with one final ...

In March, the FTC said it may consider requesting extensions if companies were not able to produce documents and employees in a timely manner ...

precedential - Third Circuit

The Court ordered Defendants to disgorge $448 million in ill-gotten profits but denied the FTC's request for an ... The FTC sued AbbVie, Abbott, ...

AbbVie Inc. and Allergan plc, In the Matter of

Our Topics library provides one-stop collections of materials on numerous issues in which the FTC has been actively engaged. These pages are ...

House Democrats request FTC investigate AbbVie's pricing of Humira

Three House Democrats called on the Federal Trade Commission (FTC) to investigate drugmaker AbbVie for its pricing of Humira, ...

AbbVie and Allergan Receive Second Request from Federal Trade ...

The effect of the Second Request is to extend the waiting period imposed by the HSR Act until 30 days after the parties have substantially ...

Chairs Maloney, Nadler, and Cicilline Ask FTC to Open Formal ...

... Federal Trade Commission (FTC) Acting Chair Rebecca Kelly Slaughter requesting a formal inquiry into AbbVie Inc.'s actions to delay U.S. ...